Weston Blakeslee

Weston Blakeslee, Ph.D. has a diverse work experience in the healthcare and technology industries. Weston is currently the Vice President of Population Health at DrFirst, Inc., where they focus on delivering clinically actionable insights and improving outcomes for high-risk populations. Prior to this role, they served as the Senior Director of Clinical Product Solutions & Innovation at DrFirst, leading the Applied Clinical Research team and conducting peer-reviewed clinical studies.

Additionally, Weston has worked as a Strategic Advisor at PatchRx, a company that improves patient health through smart technology. Weston has also served as a Chief Clinical Officer at Arrive Health (formerly RxRevu), overseeing the clinical validity of their prescription decision support platform and securing funding for its expansion.

Furthermore, Weston has experience as a Scientific Advisor at Test Appropriate, where they contributed to the development of a clinical decision support tool, and as a Biomedical Advisor at Corvectra, Inc., focusing on the development of a non-invasive biosensing diagnostic device.

Weston's earlier work experience includes roles as a PhD Candidate and Graduate Student at the University of Colorado Anschutz Medical Campus, as well as a Research Assistant at the Integrative Physiology of Aging Laboratory. Weston is also an author, having written on the topic of preparing doctoral-level students for the business world.

Weston Blakeslee, Ph.D. completed a Bachelor's Degree in Biochemistry at the University of Colorado Boulder from 2005 to 2009. Weston later pursued a Doctor of Philosophy (Ph.D.) in Pharmacology at the University of Colorado Anschutz Medical Campus from 2010 to 2015. Additionally, they obtained certifications such as the Colorado Bioscience Association Executive Leadership Program in 2019 and the CU Anschutz BESST Program Life Science Development and Commercialization in 2014.